Clinical Impact of Beta-blockers in the Revascularization Era.
作者信息
Kang Soo Jin
机构信息
Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.
出版信息
Korean Circ J. 2020 Jun;50(6):509-510. doi: 10.4070/kcj.2020.0112.
Abstract
摘要
相似文献
1
Clinical Impact of Beta-blockers in the Revascularization Era.β受体阻滞剂在血管重建时代的临床影响
Korean Circ J. 2020 Jun;50(6):509-510. doi: 10.4070/kcj.2020.0112.
2
Beta-blocker therapy reduces mortality in patients with coronary artery disease treated with percutaneous revascularization: a meta-analysis of adjusted results.β受体阻滞剂治疗经皮血运重建术治疗的冠心病患者降低死亡率：调整结果的荟萃分析。
J Cardiovasc Med (Hagerstown). 2018 Jul;19(7):337-343. doi: 10.2459/JCM.0000000000000662.
3
Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.β受体阻滞剂用于心肌梗死的临床结局：随机试验的荟萃分析
Am J Med. 2014 Oct;127(10):939-53. doi: 10.1016/j.amjmed.2014.05.032. Epub 2014 Jun 11.
4
5
Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?β受体阻滞剂对急性心肌梗死后接受冠状动脉血运重建的老年患者是否有效？
Arch Intern Med. 2000 Apr 10;160(7):947-52. doi: 10.1001/archinte.160.7.947.
6
Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.急性心肌梗死后接受最佳治疗的无心力衰竭患者停用β受体阻滞剂后的临床事件：基于法国医疗数据库的队列研究
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004356. doi: 10.1161/CIRCOUTCOMES.117.004356.
7
Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.比较成功行经皮冠状动脉介入治疗药物洗脱支架后 ST 段抬高型心肌梗死患者中β受体阻滞剂联合血管紧张素转换酶抑制剂与β受体阻滞剂联合血管紧张素Ⅱ 1 型受体阻滞剂的疗效。
Cardiovasc Drugs Ther. 2019 Feb;33(1):55-67. doi: 10.1007/s10557-018-6841-7.
8
Evolution in practice patterns and long-term outcomes of coronary revascularization from bare-metal stent era to drug-eluting stent era in Japan.日本从金属裸支架时代到药物洗脱支架时代的实践模式演变及冠状动脉血运重建的长期结果。
Am J Cardiol. 2014 May 15;113(10):1652-9. doi: 10.1016/j.amjcard.2014.02.037. Epub 2014 Mar 5.
9
Do Patients need Lifelong β-Blockers after an Uncomplicated Myocardial Infarction?患者在无并发症心肌梗死后是否需要终身服用β受体阻滞剂？
Am J Cardiovasc Drugs. 2019 Oct;19(5):431-438. doi: 10.1007/s40256-019-00338-4.
10
Usefulness of Beta blockade in contemporary management of patients with stable coronary heart disease.β受体阻滞剂在当代稳定型冠心病患者管理中的应用价值
Am J Cardiol. 2014 Nov 15;114(10):1607-12. doi: 10.1016/j.amjcard.2014.08.026. Epub 2014 Aug 27.
本文引用的文献
1
Clinical Impact of Beta Blockers in Patients with Myocardial Infarction from the Korean National Health Insurance Database.来自韩国国民健康保险数据库的β受体阻滞剂对心肌梗死患者的临床影响
Korean Circ J. 2020 Jun;50(6):499-508. doi: 10.4070/kcj.2019.0231. Epub 2020 Jan 6.
2
Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis.口服β受体阻滞剂治疗对当代心肌梗死后患者死亡率的影响：系统评价和荟萃分析。
Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):12-20. doi: 10.1093/ehjcvp/pvy034.
3
Effect of β-Blockers Beyond 3 Years After Acute Myocardial Infarction.β受体阻滞剂对急性心肌梗死后 3 年以上的影响。
J Am Heart Assoc. 2018 Mar 3;7(5):e007567. doi: 10.1161/JAHA.117.007567.
4
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).2017年欧洲心脏病学会（ESC）ST段抬高型急性心肌梗死患者管理指南：欧洲心脏病学会（ESC）ST段抬高型急性心肌梗死患者管理工作组
Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393.
5
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study.β受体阻滞剂与无心力衰竭心肌梗死患者的死亡率：多中心前瞻性队列研究
BMJ. 2016 Sep 20;354:i4801. doi: 10.1136/bmj.i4801.
6
Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.β受体阻滞剂治疗与行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者临床结局的相关性。
JACC Cardiovasc Interv. 2014 Jun;7(6):592-601. doi: 10.1016/j.jcin.2013.12.206.
7
Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials.β受体阻滞剂用于心肌梗死的临床结局：随机试验的荟萃分析
Am J Med. 2014 Oct;127(10):939-53. doi: 10.1016/j.amjmed.2014.05.032. Epub 2014 Jun 11.
8
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会ST段抬高型心肌梗死管理指南：美国心脏病学会基金会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2013 Jan 29;61(4):e78-e140. doi: 10.1016/j.jacc.2012.11.019. Epub 2012 Dec 17.
9
beta Blockade after myocardial infarction: systematic review and meta regression analysis.心肌梗死后的β受体阻滞剂治疗：系统评价与Meta回归分析
BMJ. 1999 Jun 26;318(7200):1730-7. doi: 10.1136/bmj.318.7200.1730.
Zotero 插件